back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-13 17:11 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+275,000 vol |
672,730 | |
| Filed 2024-04-02 16:40 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,738
+28,828 vol $0.095 each |
70,922 | |
| Filed 2024-04-02 16:38 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,828 vol |
135,462 | |
| Filed 2023-11-30 17:12 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
164,290 | |
| Filed 2023-05-01 13:28 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$862.16
+6,632 vol $0.13 each |
42,094 | |
| Filed 2023-05-01 13:26 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,632 vol |
64,290 | |
| Filed 2023-04-05 16:15 Tx date 2023-04-01 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$57,600
+640,000 vol $0.09 each |
640,000 | |
| Filed 2023-04-05 16:14 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-31 13:27 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,450
+28,829 vol $0.085 each |
35,462 | |
| Filed 2023-03-31 13:25 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-28,829 vol |
70,922 | |
| Filed 2022-05-05 12:08 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,724
+6,633 vol $0.26 each |
6,633 | |
| Filed 2022-05-05 12:07 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-05 12:06 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,633 vol |
99,751 | |
| Filed 2022-04-25 14:06 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+86,486 vol |
106,384 | |
| Filed 2022-04-25 14:03 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,730 vol |
397,730 | |
| Filed 2021-05-03 18:37 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+19,898 vol |
19,898 | |
| Filed 2021-05-03 18:36 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 18:36 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,188
+48,000 vol $1.61 each |
268,000 | |
| Filed 2020-06-10 19:20 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
220,000 | |
| Filed 2020-06-10 19:19 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2020-06-10 18:24 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2020-06-10 18:24 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
220,000 | |
| Filed 2019-08-08 13:00 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
| Filed 2019-08-08 12:56 Tx date 2019-05-02 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000,000 vol |
5,000,000 | |
| Filed 2019-08-08 12:55 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Foreman, Albert John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|